From Discovery to First-in-Human, Without the Delay

AES Biologics partners with biotech start-ups to fast-track microbial biologics development through rapid tech transfer, engineering-driven process development, and GMP-aligned manufacturing.

Request a Technical Consultation

Explore Capabilities

Workers in white coats operate machinery in a factory setting, focused on their tasks in a clean, organized environment.

A man in a lab coat is focused on his work while using a computer in a laboratory setting.

Biologic Development Shouldn’t Stall at Tech Transfer

Biotech startups developing recombinant proteins and enzymes face long timelines, rigid processes, and limited access to US-based capacity.

Delays at this stage slow development, putting IND timelines, funding milestone and patient impact at risk.

A CMO Built for Early-Stage Innovation

AES Biologics was created to serve biotech innovators who need speed, flexibility, and technical rigor without sacrificing regulatory discipline.

Backed by decades of experience across engineering, automation, data systems, and GMP operations, our team brings the capabilities of large CMOs into an agile, early-stage focused model designed for FIH readiness and Phase I/II clinical programs.

A Clear Path to First-in-Human Readiness

Align

Define program goals, timelines, and technical requirements through early scientific and engineering collaboration.

Build

Execute rapid tech transfer, process development, and GMP-compliant manufacturing using integrated automation and data-driven workflows.

Advance

Move forward with confidence toward IND and FIH milestones supported by compliant documentation and reproducible processes.

Why Innovators Choose AES Biologics

Engineering-driven development applied early to reduce timelines
Flexible GMP-compliant pilot suites designed for FIH programs
Integrated expertise across process development, automation, and data
Transparent, collaborative partnership model

Female lab worker in a white coat writing notes on a clipboard in a laboratory setting.

Built to Reduce Risk at the Most Critical Stage

When development stalls, programs lose time, funding opportunities, and momentum due to a lack of confidence. AES Biologics pairs automation with standardized GMP-compliant workflows, ensuring reproducibility, reduced human error, and flawless scale-up.

Commercial readiness starts long before the first GMP run.

Backed by the Full Strength of AES

AES Biologics operates as part of the AES organization, giving our clients access to far more than standalone CMO capabilities.

Through AES, AES Biologics operates within a fully integrated biotech ecosystem spanning process engineering, automation, data systems, staffing, facility readiness, and GMP execution. This integration allows us to support clients beyond clinical material production, providing the infrastructure and workflows needed to scale with confidence.

Let's Move Your Program Forward

If you’re preparing for IND or first-in-human milestones and need a CMO built for fast timelines and disciplined execution, AES Biologics is uniquely positioned to support biotech innovators from sequence to lab to GMP production. We help you move forward through rapid tech transfer, focused process development, and GMP-aligned manufacturing that supports regulatory confidence.

Request a Technical Consultation